secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tango Therapeutics, Inc. (TNGX)
CIK:        0001819133
Form:       8-K
Filed at:   2024-06-06T23:59:59+00:00
Accession:  0001193125-24-156048
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tango Therapeutics stockholders approve officer liability limit and elect directors at 2024 annual meeting
--------------------------------------------------------------------------------

- Shareholders approved amendment to Second Amended and Restated Certificate of Incorporation to limit officer liability under Delaware law (89.9M for, 5.5M against).
- Elected Alexis Borisy, John Ketchum, and Barbara Weber as Class III directors each with >90M votes for.
- Ratified PricewaterhouseCoopers as independent auditor for FY2024 (100.7M for, 2K against).
- Quorum of 94.35% (100.7M shares) present at virtual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819133/000119312524156048/0001193125-24-156048-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819133/000119312524156048/d768398d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-156048

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer